1228 CHARACTERIZATION OF NOVEL, HIGHLY POTENT NS5A INHIBITORS WITH QD DOSING POTENTIAL AND ROBUST ACTIVITY IN AN HCV CHIMERIC ANIMAL MODEL von Nicholas, J.B, Buckman, B.O, Serebryany, V, Schaefer, C.J, Kossen, K, Ruhrmund, D, Hooi, L, Aleskovski, N, Arfsten, A, Lim, S.R, Pan, L, Huang, L, Rajagopalan, R, Misialek, S, Seiwert, S

Volltext

1196 NOVEL, POTENT, PAN-GENOTYPIC HCV NS3/4A PROTEASE INHIBITORS WITH A HIGH BARRIER TO RESISTANCE von Buckman, B.O, Kossen, K, Nicholas, J.B, Serebryany, V, Ruhrmund, D, Rajagopalan, R, Misialek, S, Hooi, L, Aleskovski, N, Pan, L, Huang, L, Schaefer, C.J, Rajyaguru, S, Le Pogam, S, Nájera, I, Klumpp, K, Seiwert, S

Volltext